Proto Labs former officer plans $109K share sale

The shares are identified as acquired from the issuer through option exercise under a registered plan, with cash payment.

Available on EDGAR 09/25/2026 - 04:32 PM EDT Accepted by SEC EDGAR 09/25/2026 - 04:21 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Proto Labs, Inc. (PRLB) former officer Michael R. Kenison reported an intended sale of 1,143 common shares, with an aggregate market value of $109,493.69, through Morgan Stanley Smith Barney LLC, dated September 25, 2026. The shares are identified as acquired from the issuer through exercise of options under a registered plan, with cash payment. Kenison's reported sales during the prior three months included 1,800 shares for $172,534.50 on September 24, 2026, and 10,753 shares for $947,786.62 on August 4, 2026.

Key Figures

Common shares intended for sale: 1,143 shares Aggregate market value: $109,493.69 Prior shares sold: 1,800 shares +3 more

6 metrics

Common shares intended for sale 1,143 shares Former officer's reported sale dated September 25, 2026

Aggregate market value $109,493.69 Reported sale of 1,143 common shares

Prior shares sold 1,800 shares September 24, 2026

Prior sale value $172,534.50 Sale of 1,800 shares on September 24, 2026

Prior shares sold 10,753 shares August 4, 2026

Prior sale value $947,786.62 Sale of 10,753 shares on August 4, 2026

Key Terms

Rule 144, Exercise of Options Under a Registered Plan

2 terms

Rule 144 regulatory

"sales are required by paragraph (e) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Exercise of Options Under a Registered Plan financial

"Exercise of Options Under a Registered Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PRLB shares did former officer Michael R. Kenison plan to sell?

Former officer Michael R. Kenison reported an intended sale of 1,143 Proto Labs common shares, with an aggregate market value of $109,493.69. The approximate sale date listed is September 25, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001870293
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PROTO LABS, INC.
SEC File Number	001-35435
Address of Issuer	5540 Pioneer Creek Drive Maple Plain MINNESOTA 55359
Phone	763-479-3680
Name of Person for Whose Account the Securities are To Be Sold	MICHAEL R KENISON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1143	109493.69	23921897	09/25/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/25/2026	Exercise of Options Under a Registered Plan	Issuer			1143	09/25/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MICHAEL R KENISON 5540 Pioneer Creek Drive Maple Plain MN 55359	Common	09/24/2026	1800	172534.50
MICHAEL R KENISON 5540 Pioneer Creek Drive Maple Plain MN 55359	Common	08/04/2026	10753	947786.62

144: Remarks and Signature

Remarks
Date of Notice	09/25/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Michael Roy Kenison
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)